ARGX – argenx se - american depositary shares (US:NASDAQ)
Stock Stats
News
argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $639.00 to $723.00. They now have an "overweight" rating on the stock.
Should You Increase Your Holdings in argenx SE (ARGX)? [Yahoo! Finance]
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $655.00 price target on the stock.
Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]
Form 6-K ARGENX SE For: Dec 27
Form 6-K ARGENX SE For: Nov 20
Form SC 13G/A ARGENX SE Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Form SC 13G/A ARGENX SE Filed by: FMR LLC
Form 6-K ARGENX SE For: Nov 12
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.